Oncology & Cancer

Oral HPV infection, HPV-related cancers more common in men

Oral HPV infection is more common among men than women, explaining why men are more prone than women to develop an HPV related head and neck cancer, according to a study presented at the Multidisciplinary Head and Neck Cancer ...

Oncology & Cancer

Researchers develop and test new anti-cancer vaccine

Researchers at Moffitt Cancer Center have developed and tested in mice a synthetic vaccine and found it effective in killing human papillomavirus-derived cancer, a virus linked to cervical cancers among others. The research ...

Oncology & Cancer

Cervical vaccine also protects against anal cancer risk

A vaccine routinely used to shield against cervical cancer caused by the human papillomavirus also reduces women's risk of anal cancer, a study published by the journal The Lancet Oncology on Tuesday says.

Oncology & Cancer

Cervical cancer symptoms not recognised by young women

(Medical Xpress)—New research led by King's College London suggests that many women under 30 with cervical cancer are diagnosed more than 3 months after first having symptoms. In many cases this was because they did not ...

Medications

Parents' decision-making in HPV vaccination of daughters analyzed

Human Papillomavirus (HPV) is a leading cause of sexually transmitted diseases, with more than 70% of sexually active people getting the virus at least once in their lifetimes. Persistent infection with some HPV strains can ...

Oncology & Cancer

Fewer than three doses of cervical cancer vaccine effective

Fewer than three doses of the human papillomavirus (HPV) vaccine Cervarix may be just as effective as the standard three-dose regimen when it comes to preventive measures against cervical cancer, according to a new study ...

page 2 from 9